The site is highly sustainable and the first drug product manufacturing plant in
Chile
to obtain approval by an EU health authority to manufacture products for the EU market. With its 350 employees, the site handles over 50 different products (molecules/strengths) from both the local and
Synthon’s
global portfolio. go to
Synthon Chile
website